Timing of NTRK Gene Fusion Testing and Treatment Modifications Following TRK Fusion Status Among US Oncologists Treating TRK Fusion Cancer

Conclusion and RelevanceAmong patients with advanced/metastatic TRK fusion cancer, medical oncologists reported testing forNTRK fusions at diagnosis or prior to 1L. Future research should elucidate why fewer than half of oncologists surveyed (46%) would not use TRKis afterNTRK+ status confirmation, assess clinical practices amongNTRK+ patients, and characterize treatment patterns and clinical outcomes in real-world settings.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research